Skip to main content
. 2017 Apr 17;17:272. doi: 10.1186/s12885-017-3258-9

Fig. 3.

Fig. 3

Mean (SD) scores for lenvatinib for RR-DTC assigned to each quantitative criterion by the French (a), Italian (b), and Spanish (c) panels versus watchful waiting (1) and sorafenib (2). A constructed, cardinal scoring scale was used, ranging from 0 to 5 for non-comparative and from −5 to 5 for comparative criteria